170 related articles for article (PubMed ID: 38545256)
1. JAK3/STAT5 signaling-triggered upregulation of PIK3CD contributes to gastric carcinoma development.
Hu Q; Dou N; Wu Q; Gao Y; Li Y; Chen J
J Cell Commun Signal; 2024 Mar; 18(1):e12017. PubMed ID: 38545256
[TBL] [Abstract][Full Text] [Related]
2. SP1 Mediated PIK3CB Upregulation Promotes Gastric Carcinogenesis.
Fan K; Hu Q; Yu S; Gao Y; Li Y
J Cancer; 2024; 15(5):1355-1365. PubMed ID: 38356702
[TBL] [Abstract][Full Text] [Related]
3. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
[TBL] [Abstract][Full Text] [Related]
5. Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.
Wang M; Chen L; Chen Y; Wei R; Guo Q; Zhu S; Guo S; Zhu S; Zhang S; Min L
Mol Oncol; 2020 May; 14(5):1045-1058. PubMed ID: 32086862
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of PIK3CD in glioblastoma is exerted through cytoskeletal proteins PAK3 and PLEK2.
Shao W; Azam Z; Guo J; To SST
Lab Invest; 2022 Dec; 102(12):1314-1322. PubMed ID: 35851857
[TBL] [Abstract][Full Text] [Related]
7. GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.
Xu W; Jiang T; Shen K; Zhao D; Zhang M; Zhu W; Liu Y; Xu C
Front Endocrinol (Lausanne); 2023; 14():1224832. PubMed ID: 37608794
[TBL] [Abstract][Full Text] [Related]
8. p110δ PI3K as a therapeutic target of solid tumours.
Xenou L; Papakonstanti EA
Clin Sci (Lond); 2020 Jun; 134(12):1377-1397. PubMed ID: 32556179
[TBL] [Abstract][Full Text] [Related]
9. Isoform-selective induction of human p110δ PI3K expression by TNFα: identification of a new and inducible PIK3CD promoter.
Whitehead MA; Bombardieri M; Pitzalis C; Vanhaesebroeck B
Biochem J; 2012 May; 443(3):857-67. PubMed ID: 22375552
[TBL] [Abstract][Full Text] [Related]
10. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
[TBL] [Abstract][Full Text] [Related]
11. Aberrant PI3Kδ splice isoform as a potential biomarker and novel therapeutic target for endocrine cancers.
Ha S; Gujrati H; Wang BD
Front Endocrinol (Lausanne); 2023; 14():1190479. PubMed ID: 37670888
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide 3-kinase p110δ mediates estrogen- and FSH-stimulated ovarian follicle growth.
Li Q; He H; Zhang YL; Li XM; Guo X; Huo R; Bi Y; Li J; Fan HY; Sha J
Mol Endocrinol; 2013 Sep; 27(9):1468-82. PubMed ID: 23820902
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway.
Chen H; Dai G; Cai Y; Gong Q; Wu W; Gao M; Fei Z
Cancer Cell Int; 2018; 18():97. PubMed ID: 30002604
[TBL] [Abstract][Full Text] [Related]
14. The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
Pridham KJ; Varghese RT; Sheng Z
Front Oncol; 2017; 7():312. PubMed ID: 29326882
[TBL] [Abstract][Full Text] [Related]
15. PIK3CD correlates with prognosis, epithelial-mesenchymal transition and tumor immune infiltration in breast carcinoma.
He W; Zhang H; Cheng H; Wen J; Li D
Discov Oncol; 2023 Oct; 14(1):187. PubMed ID: 37861728
[TBL] [Abstract][Full Text] [Related]
16. PTEN-deficient cancers depend on PIK3CB.
Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
[TBL] [Abstract][Full Text] [Related]
17. miR-30a suppresses cell migration and invasion through downregulation of PIK3CD in colorectal carcinoma.
Zhong M; Bian Z; Wu Z
Cell Physiol Biochem; 2013; 31(2-3):209-18. PubMed ID: 23486085
[TBL] [Abstract][Full Text] [Related]
18. ARHGEF39 promotes gastric cancer cell proliferation and migration via Akt signaling pathway.
Wang H; Li M; Tao X; Qian Y; Chen L; Tao G
Mol Cell Biochem; 2018 Mar; 440(1-2):33-42. PubMed ID: 28871449
[TBL] [Abstract][Full Text] [Related]
19. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells.
Song W; Zhang J; Zhang J; Sun M; Xia Q
Cancer Cell Int; 2019; 19():150. PubMed ID: 31624469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
